Xencor | XNCR - Efectivo Y Equivalentes

Precio De Mercado
12.42
Cambio Diario
-0.11 -0.88%
Mensual
3.16%
Anual
45.43%
Q2 Expectativa
12.08




Efectivo Y Equivalentes Cambio Fecha
AbbVie USD 5.23B 400M 2025-12
Alnylam Pharmaceuticals USD 1.66B 167M 2025-12
Amgen USD 9.13B 316M 2025-12
Arrowhead Research USD 201.64M 112.94M 2025-12
AstraZeneca USD 8.14B 1.08B 2025-09
Biogen USD 3.01B 854.3M 2025-12
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Cytokinetics USD 122.52M 102.95M 2025-12
GlaxoSmithKline GBP 3.3B 303M 2025-09
J&J USD 19.71B 1.48B 2025-12
Karyopharm Therapeutics USD 60.54M 22.87M 2025-12
MacroGenics USD 57.22M 22.91M 2025-12
Merck USD 18.17B 10.16B 2025-09
Novartis USD 9.56B 2.9B 2025-09
Pfizer USD 1.34B 295M 2025-09
Regeneron Pharmaceuticals USD 18.87B 16.36B 2025-12
Roche Holding CHF 7.55B 579M 2025-06
Xencor USD 54.07M 25.78M 2025-12